Was isolated at the Sacco hospital in Milanin the laboratory of clinical microbiology, virology and diagnostics of bioemergences, the monkeypoxvirus responsible for the monkeypox epidemic currently present in Europe.
“This represents an important result for scientific research – commented the Lombard vice president Letizia Moratti – it will be possible to test the activity of antiviral drugs and test the antibody response of patients who have contracted the infection and of the proportion of the population vaccinated against the smallpox virus “.
OMS – “We do not know if we’re just seeing the tip of the iceberg“, he said just today Sylvie Brianddirector of WHO’s global infectious risk preparedness department, during a presentation to member states on the spread of the virus.
Experts are trying to determine what caused this “unusual situation” and preliminary results show no variations or mutations in the monkeypox virus, he added.
“We have a window of opportunity to stop the broadcast,” continued Briand. “If we put the right measures in place now, probably we can contain it quickly“.
Meanwhile, in Italy a new case has been registered and the infections are growing day by day in various countries: in Spain those confirmed have risen from 84 to 98 and another 16 cases have been identified in the United Kingdom, bringing the total to 106.
VACCINES – A situation that it pushed the EU to take immediate countermeasures. Through the European Authority for the preparation and response to health emergencies (Hera), the European Union is indeed working on a centralized purchase of vaccines and antivirals.
Vaccination, according to EU sources, will in any case be limited “to very specific cases” given that transmissibility and risk associated with monkeypox “are not comparable” with Covid.
(Unioneonline/l.f.)
© All rights reserved